Warrants (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Jan. 31, 2021 |
Jan. 31, 2020 |
|
| Warrants | ||
| Warrants outstanding shares, Beginning | 3,000,000 | 3,000,000 |
| Exercised, shares | 75,000 | 0 |
| Granted, shares | 0 | 0 |
| Warrants outstanding shares, Ending | 2,675,000 | 3,000,000 |
| Cancelled, shares | 250,000 | |
| Warrants outstanding weighted average conversion price, Beginning | $ 1.00 | $ 1.00 |
| weighted average conversion price, Exercised | 1.00 | 0 |
| Weighted average conversion price, Granted | 0.00 | 0 |
| Weighted average conversion price, Cancelled | 1.00 | |
| Warrants outstanding weighted average conversion price, Ending | $ 1.00 | $ 1.00 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. No definition available.
|